KACTUS has developed a GMP-grade universal nuclease – MaxNuclease™, which degrades all DNA and RNA into 2-5 base oligonucleotides.
KACTUS: Endonuclease – MaxNuclease™ GMP-Grade

KACTUS has developed a GMP-grade universal nuclease – MaxNuclease™, which degrades all DNA and RNA into 2-5 base oligonucleotides.
KACTUS has developed a series of high-quality CAR-T target protein products, covering a wide range of popular targets such as CD19, BCMA, and MSLN.
At KACTUS, they offer a comprehensive range of high-quality recombinant HLA-G and LILR proteins, to support research and development in immunology and therapeutic applications.
KACTUS have developed a series of immune checkpoint proteins with various tags.
KACTUS has developed a full portfolio of tag-free or small-tag cytokines with verified cellular-level bioactivity for various cell culture applications.
KACTUS provides a variety of highly active CD3 proteins, including monomers, dimers, and other forms, to meet the diverse needs of researchers.
KACTUS’ high-quality CD19 proteins are designed for applications such as antibody screening, CAR-T cell therapy development and affinity measurements.
All the analytical tools you need for your research: in vivo products, tetramers, ELISAs, small molecules & proteins (RUO & GMP)!
In order to provide the most biologically active proteins, many of Leinco Technologies’ proteins are expressed using mammalian host cells,
Originally published on Forbes –
Thinking Outside The Tank: Why This Startup Thinks Fruit Flies Will Solve Synbio’s Scale-Up Problem